Norwegian National Air Ambulance Services Choose Danish Blood/IV Fluid Warmer, ̊M Warmer System ( ̊MEQU)

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

March 22, 2021

Norwegian National Air Ambulance Services

 

˚MEQU, an innovative MedTech company from Denmark, is pleased to announce that it has won a public tender to provide portable blood and IV-fluid warming devices (˚M Warmer System) to Norwegian National Air Ambulance Services (Luftambulansetjenesten HF). 

Norwegian National Air Ambulance Services is responsible for all air ambulances (both fixed-wing and helicopters) and acute cars located at 13 bases throughout the country and is one of the most innovative and advanced HEMS (helicopter emergency medical services) programs in the world. The ˚M Warmer System was the only device meeting all mandatory requirements and was chosen due to its high quality – small size and light weight, heating capacity, and not least user-friendliness.

Prehospital fluid resuscitation is known to increase the survival rate of trauma patients. For this reason, carrying blood products onboard aircraft has been initiated by major European HEMS in recent years despite its complex and costly process in terms of blood supply and staff training. Moreover, aircraft should be equipped with a blood/IV fluid warmer as all fluids should be warmed up to body temperature before the infusion to avoid unnecessary cooling of the patient.

Ulrik Krogh Andersen (CEO) commented,“prehospital fluid resuscitation before arriving at a hospital is shown to significantly reduce mortality among severely injured patientsWe are thankful that Norwegian National Air Ambulance Services chose our ˚M Warmer System to treat their patients, so we accelerate our mission to improve the survival and recovery rate of patients in critical situations.”

Peter Skade (GLOBAL SALES DIRECTOR) commented, “winning this tender is a confirmation that ˚M Warmer System is a superior solution as it is easy to set up and use and has efficient and powerful warming capacity. The ˚M Warmer System is now adopted by leading HEMS throughout the Nordic countries, UK, mainland Europe and Australia.”

The ˚M Warmer System was awarded the Red Dot Design Award in 2018 for its minimalist expression, user-friendliness, and intuitive design that together reduce the risk of human errors and delays. ˚M Warmer is currently used both in pre-hospital and in-hospital settings, and ˚MEQU is continuously developing its technology to bring warm blood and IV fluids to more patients.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles